News & Alerts
-
Feb- 2024 -12 February
Novo Nordisk’s Controlling Shareholder Plans To Invest About $7 Billion a Year By 2030
Novo Holdings, the controlling shareholder of Novo Nordisk, a prominent Danish pharmaceutical company known for its focus on obesity and…
Read More » -
9 February
Why Poland is an Appropriate Destination for Breast Augmentation?
Breast augmentation, a procedure to enhance the size and shape of a woman’s breasts, has become increasingly popular worldwide. Poland,…
Read More » -
9 February
New Study Reports How Some Erectile Dysfunction Meds May Affect Alzheimer’s Risk
A recent study published in Neurology suggests that men prescribed drugs to treat newly diagnosed erectile dysfunction (ED) may have…
Read More » -
9 February
U.S. Senate Democrats Grill Pharma CEOs Over High Drug Prices
On Thursday, U.S. Senate Democrats took a hard stance on the issue of prescription drug prices, grilling three prominent pharmaceutical…
Read More » -
9 February
Precision Gerontology: Caring for an Aging Population
It’s often said that there are only two constants in life – death and taxes. While that’s partially true there…
Read More » -
8 February
AstraZeneca’s Portfolio Booms As it Targets 2024 Growth
AstraZeneca PLC is poised for growth in 2024 as its robust portfolio of cancer and rare disease drugs continues to…
Read More » -
7 February
Best Ways to Save on Freestyle Libre 3 Sensor
Freestyle Libre 3 Sensor is a continuous glucose monitoring (CGM) system developed by Abbott. It’s designed to help people with…
Read More » -
7 February
U.S. Department of Homeland Security (DHS) to Hire 50 AI Experts to Crack Down on Drugs, Child Abuse
The U.S. Department of Homeland Security (DHS) has announced plans to bolster its capabilities in combating a range of pressing…
Read More » -
5 February
New Study Says Zepbound May Significantly Lower Blood Pressure In Overweight Adults
In a groundbreaking study published on February 5, Eli Lilly’s revolutionary weight loss drug, Zepbound, has shown promising results in…
Read More » -
5 February
TING 1% Athlete’s Foot Spray Recalled Due to Elevated Benzene Levels
Insight Pharmaceuticals is recalling two lots of TING 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid due to elevated levels…
Read More »
